Piramal Pharma P/B Ratio
Piramal Pharma (PPLPHARMA) P/B ratio is 2.92 (Moderate), book value per share ₹61.51 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. View PPLPHARMA 52-week chart for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PPLPHARMA P/B Ratio — Valuation Insights & Book Value Analysis
Piramal Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 2.92 (Moderate). Compare with PPLPHARMA fair price to assess whether the stock is under or overvalued.
- Trading at premium to sector average PB of -0.33
Piramal Pharma P/B Ratio Historical Trend
PPLPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see PPLPHARMA screener.
PPLPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price
Piramal Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.83 | ₹61.51 | ₹174.24 | ₹8,163 | Moderate |
| 2025 | 2.81 | ₹61.37 | ₹172.21 | ₹8,126 | Moderate |
| 2024 | 4.45 | ₹59.8 | ₹266.25 | ₹7,911 | High |
| 2023 | 2.45 | ₹56.78 | ₹138.85 | ₹6,774 | Moderate |
| 2022 | 1.98 | ₹56.47 | ₹111.95 | ₹6,697 | Moderate |
PPLPHARMA vs Healthcare Peers — P/B Ratio Comparison
Piramal Pharma P/B 2.92 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |